Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients

Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1571-1573, June 2018.

Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: D. Dutzer , Y. Nasser , A. E. Berger , X. Roblin , S. Paul Source Type: research